Dual Mode of Action Herbicide for Broadleaf Weed Management

Agricultural producers across South America face diminishing chemical control options as high-density weed populations evolve resistance to multiple foundational herbicide classes. In Brazil, where approximately 50 million hectares of soybean and over 20 million hectares of corn are under active cultivation, the rapid spread of multi-resistant broadleaf species poses severe operational challenges. To deliver a differentiated chemical pathway capable of breaking established cross-resistance cycles, FMC Corporation initiated the formal registration process with Brazilian regulatory authorities for rimisoxafen, the agricultural industry’s first herbicide active ingredient featuring dual modes of action.

Agronomic Resistance Drivers Across Brazilian Cropping Systems
Commercial grain rotations in tropical and subtropical regions depend heavily on reliable pre- and post-emergence weed control to protect early vegetative crop stages. However, continuous application schedules have accelerated the proliferation of biotypes resistant to EPSPS inhibitors like glyphosate and acetolactate synthase (ALS) inhibitors.

Among the most damaging targets is Amaranthus hybridus (smooth pigweed), which has developed documented resistance across major soybean-producing zones. Concurrently, Amaranthus palmeri (Palmer amaranth)—a regulated quarantine weed in Brazil characterized by aggressive daily biomass accumulation and prolific seed production—threatens row-crop yields by competing directly for light, nutrients, and soil moisture. Conventional tank mixes increasingly struggle to suppress these populations without elevating application frequencies or requiring supplemental field interventions.

Dual Mode of Action Architecture and Field Performance
Rimisoxafen is classified by the Herbicide Resistance Action Committee (HRAC) under both Group 12 and Group 32. This dual classification provides a biochemical profile that simultaneously acts on two separate biological target sites within the plant.

In agronomic research trials conducted by FMC, the molecule exhibited consistent pre-emergence and residual activity against small-seeded broadleaf weeds, including biotypes displaying confirmed resistance to single-site chemical groups. By delivering two concurrent modes of action in a single molecule, the active ingredient reduces the probability that target populations will develop target-site mutations, providing growers with a tool to diversify weed management programs and preserve the longevity of existing chemical modes of action.

Active Ingredient Pipeline and Regulatory Timeline
The Brazilian submission for rimisoxafen follows a July 2026 filing submitted to the United States Environmental Protection Agency (EPA), marking the molecule's second major regulatory milestone in leading global grain-producing nations.

The active ingredient represents the third proprietary herbicide compound advanced to regulatory authorities in Brazil by FMC, following Isoflex active (bixlozone) and Dodhylex active (tetflupyrolimet). Formulated product dossiers are slated to follow as technical ingredient evaluations progress through local governing agencies. Commercial sale and field application remain contingent upon formal regulatory approval across all evaluating departments.

Additional Context:
This section details technical specifications and competitive benchmarking not included in the original product announcement.

The chemical classification of rimisoxafen under HRAC Group 12 and Group 32 represents a significant structural departure from traditional herbicide design, which historically couples distinct modes of action only through co-formulations or physical tank mixes. HRAC Group 12 active ingredients (such as fluridone, norflurazon, and diflufenican) function as phytoene desaturase (PDS) inhibitors, blocking carotenoid biosynthesis and exposing photosynthetic tissues to photo-oxidative degradation. HRAC Group 32 includes solanesyl diphosphate synthase (SPP synthase) inhibitors, such as bixlozone (FMC’s Isoflex active), which disrupt plastoquinone and carotenoid production via an upstream isoprenoid pathway.

In commercial soybean and corn production, standard resistance-breaking strategies have historically relied on tank-mixing Group 15 very-long-chain fatty acid (VLCFA) inhibitors (such as S-metolachlor or pyroxasulfone) with Group 14 protoporphyrinogen oxidase (PPO) inhibitors (such as flumioxazin or fomesafen) or Group 5 photosystem II inhibitors (such as metribuzin). While these multipronged mixtures provide broad spectrum control, their physical combination does not prevent metabolic resistance mechanisms capable of degrading separate chemical classes independently. A single chemical active ingredient possessing two complementary targets inside the chloroplast isoprenoid and pigment pathways provides a unified resistance barrier that target weed species cannot evade through standard single-locus target-site mutations.

Edited by Natania Lyngdoh, Induportals editor, with AI assistance.

www.fmc.com